Dylan Johnson

Dylan Johnson

Auto-generated profile, based on publicly available information

Dylan Johnson

Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, National Institutes of Health, Durham, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2018 in Biochimica et Biophysica Acta (BBA) - Biomembranes
Verified
Journal Article
Closed access
SWStephen R. Wassall
Stephen R. Wassall
XLXiaoling Leng
Xiaoling Leng
SCSamuel W. Canner
Samuel W. Canner
EPEdward Ross Pennington
Edward Ross Pennington
JKJacob Kinnun
Jacob Kinnun
SSSaame Shaikh
Saame Shaikh

15 January 2019 in Molecular Biology of the Cell
Verified
Journal Article
Open access
TLThu Ly
Thu Ly
CPChristopher T. Pappas
Christopher T. Pappas
DJDylan Johnson
Dylan Johnson
WSWilliam Schlecht
William Schlecht
MCMert Colpan
Mert Colpan
MMMonitoring Editor Thomas M. Magin
Monitoring Editor Thomas M. Magin
Missense mutations K15N and R21H in striated muscle tropomyosin are linked to dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM), respectively. Tropomyosin, together with the troponin complex, regulates muscle contraction and, along with tropomodulin and leiomodin, controls the uniform thin-filament lengths crucial for normal sarcomere structure and function. We used Förster resonance energy transfer to study effects of the tropomyosin mutations on the structure and kinetics of the cardiac troponin core domain associated with the Ca2+-dependent regulation of cardiac thin filaments. We found that the K15N mutation desensitizes thin filaments to Ca2+and slows the kinetics of structural changes in troponin induced by Ca2+dissociation from troponin, while the R21H mutation has almost no effect on these parameters. Expression of the K15N mutant in cardiomyocytes decreases leiomodin’s thin-filament pointed-end assembly but does not affect tropomodulin’s assembly at the pointed end. Our in vitro assays show that the R21H mutation causes a twofold decrease in tropomyosin’s affinity for F-actin and affects leiomodin’s function. We suggest that the K15N mutation causes DCM by altering Ca2+-dependent thin-filament regulation and that one of the possible HCM-causing mechanisms by the R21H mutation is through alteration of leiomodin’s function.

22 May 2017 in Biochemistry
Verified
Journal Article
Closed access
TBTamatha Baxley
Tamatha Baxley
DJDylan Johnson
Dylan Johnson
JPJose Renato Pinto
Jose Renato Pinto
JCJoseph M. Chalovich
Joseph M. Chalovich

21 August 2018 in Biophysical Journal
Verified
Journal Article
Closed access
DJDylan Johnson
Dylan Johnson
CAC. William Angus
C. William Angus
JCJoseph M. Chalovich
Joseph M. Chalovich

31 August 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
PDF file
JCJoseph M. Chalovich
Joseph M. Chalovich
DJDylan Johnson
Dylan Johnson
A commentary on Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin by Eisenberg, E., and Weihing, R. R. (1970). Nature 228, 1092–1093. doi: 10.1038/2281092a0 Troponin-tropomyosin inhibits skeletal and cardiac muscle contraction at low Ca2+. Binding of rigor-type myosin S1 to actin-tropomyosin-troponin, particularly at saturating Ca2+, produces activation of myosin ATPase activity in excess of that seen in the absence of the regulatory proteins. The binding energy of S1 can overcome the inhibitory activity of troponin (Bremel et al., 1972) and may allow tropomyosin to move deep into the groove of actin. That particular arrangement of actin, tropomyosin, and troponin is a much better activator of ATP hydrolysis than actin alone. That active configuration of actin was called state 2 in the Hill model (Hill et al., 1980) and later named the M state because of its requirement for tight myosin binding. Eisenberg and Weihing found evidence that troponin itself can stabilize the active state of actin in the absence of high affinity S1 binding (Eisenberg and Weihing, 1970). They showed that troponin-tropomyosin enhanced the ability of amoeba actin to activate myosin S1 ATPase activity at high Ca2+. That observation is often overlooked but may be an important clue to managing some muscle disorders. Actin filaments containing the hypertrophic cardiomyopathy associated Δ14 mutation of TnT also enhanced S1 ATPase rates 2-3-fold higher than actin filaments without bound regulatory proteins (Gafurov et al., 2004). Because small changes in the structure of actin or troponin allow this increased activation to occur, the troponin complex must have a latent ability to enhance actin activation of myosin ATPase activity. The 14 C-terminal residues of TnT attenuate the ability of troponin to enhance actin activation. Troponin containing Δ14 TnT might act by stabilizing tropomyosin in the M state position of the actin groove under saturating Ca2+ conditions. The inactive state of actin-tropomyosin-troponin (state 1 or the B state) occurs at low free Ca2+ when the inhibitory region of TnI is bound to actin. Because of associations among the regulatory proteins, tropomyosin is stabilized outside of the actin groove and there is little stimulation of myosin ATPase activity. Removal of the 14 C-terminal residues of TnT prevents formation of the B state. Compared with wild type actin filaments in EGTA, those containing Δ14 TnT exhibit less cooperativity in equilibrium binding of myosin S1 (Gafurov et al., 2004), and they do not exhibit the acrylodan tropomyosin fluorescence increase under conditions favoring the inactive state (Borrego-Diaz and Chalovich, 2010; Franklin et al., 2012). Ca2+ binding to TnC opens a hydrophobic patch to which the switch region of TnI can bind (Herzberg et al., 1986). Under this condition, TnI is detached from actin and tropomyosin is situated in the actin groove. Several lines of evidence indicate that the major state formed with Ca2+ is a second inactive state with tropomyosin partially in the actin groove (Trybus and Taylor, 1980; McKillop and Geeves, 1991; Lehman et al., 2001; Kimura et al., 2002; Pirani et al., 2005; Poole et al., 2006). Full movement into the groove to form the active M state requires rigor S1 binding or a structural change in troponin. In the Hill model of regulation, Ca2+ binding to troponin was thought to create an inactive state 1 with bound Ca2+. State 1 with bound Ca2+ may be equivalent to the state intermediate between the B and M states that is called the C state (because of its link to Ca2+). The level of activation of ATPase activity at saturating Ca2+ is determined by the amount of M state formed in its equilibrium with the C state. The major state formed with Δ14 TnT containing actin filaments at low Ca2+ is likely to be the C state as the B state cannot form. The C state is also stabilized by a hypertrophic cardiomyopathy causing mutation, R146G TnI. The R146G mutation in TnI gives relative stabilization to the C state at low Ca2+ and the C state is highly stabilized at saturating Ca2+(Mathur et al., 2009). An analysis of ATPase rates of R146G TnI containing actin filaments supported the idea that the C state is ineffective in stimulating myosin ATPase activity. Studying natural mutations and modifications of troponin has given muscle researchers insights into the regulation of contraction. Long term deviations from the normal distribution of B, C, and M states of regulated actin seem to lead to progressive cardiac dysfunction. The last 14 residues of human cardiac TnT are critical for controlling the equilibria among the B, C, and M states of regulated actin; they stabilize the B state at low Ca2+ and destabilize the M state at saturating Ca2+. Table 1 compares the C-terminal sequences of several forms of troponin T. Note the conservation of the four terminal residues and the pattern of basic residues (bold). The regularly spaced basic residues suggest the possibility of acidic target sites for controlling both the B and M states. Table 1. C-terminal troponin T sequence comparison. The C-terminal region of TnT might function by directly affecting movement of tropomyosin on the actin surface. The C-terminal region could destabilize the active M state at saturating Ca2+ by interfering with tropomyosin movement into the actin groove. At low Ca2+, the C-terminal region of TnT could participate in holding tropomyosin away from the actin groove. The C-terminal 14 residues of TnT could also potentially alter the pathway of transmission of information from Ca2+ binding to TnC through the events leading to tropomyosin repositioning. Deciphering the mechanisms of action of the C-terminal region of TnT may lead to new therapies for cardiac disorders. All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication. Funded by NIH grant AR44504 and the Brody Brothers Grant to JC. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Borrego-Diaz, E., and Chalovich, J. M. (2010). Kinetics of regulated actin transitions measured by probes on tropomyosin. Biophys. J. 98, 2601–2609. doi: 10.1016/j.bpj.2010.02.030 PubMed Abstract | CrossRef Full Text | Google Scholar Bremel, R. D., Murray, J. M., and Weber, A. (1972). Manifestations of cooperative behavior in the regulated actin filament during actin-activated ATP hydrolysis in the presence of calcium. Cold Spring Harb. Symp. Quant. Biol. (Basel) 37, 267–275. Google Scholar Eisenberg, E., and Weihing, R. R. (1970). Effect of skeletal muscle native tropomyosin on the interaction of amoeba actin with heavy meromyosin. Nature 228, 1092–1093. doi: 10.1038/2281092a0 PubMed Abstract | CrossRef Full Text | Google Scholar Franklin, A. J., Baxley, T., Kobayashi, T., and Chalovich, J. M. (2012). The C-terminus of troponin T is essential for maintaining the inactive state of regulated actin. Biophys. J. 102, 2536–2544. doi: 10.1016/j.bpj.2012.04.037 PubMed Abstract | CrossRef Full Text | Google Scholar Gafurov, B., Fredricksen, S., Cai, A., Brenner, B., Chase, P. B., and Chalovich, J. M. (2004). The Δ14 mutation of human cardiac troponin T enhances ATPase activity and alters the cooperative binding of S1-ADP to regulated actin. Biochemistry 43, 15276–15285. doi: 10.1021/bi048646h PubMed Abstract | CrossRef Full Text | Google Scholar Herzberg, O., Moult, J., and James, M. N. (1986). A model for the Ca2+-induced conformational transition of troponin C. A trigger for muscle contraction. J. Biol.Chem. 261, 2638–2644. PubMed Abstract | Google Scholar Hill, T. L., Eisenberg, E., and Greene, L. E. (1980). Theoretical model for the cooperative equilibrium binding of myosin subfragment 1 to the actin-troponin-tropomyosin complex. Proc. Natl. Acad. Sci. U.S.A. 77, 3186–3190. PubMed Abstract | Google Scholar Kimura, C., Maeda, K., Maeda, Y., and Miki, M. (2002). Ca2+S1-induced movement of troponin T on reconstituted skeletal muscle thin filaments observed by fluorescence energy transfer spectroscopy. J. Biochem. 132, 93–102. doi: 10.1093/oxfordjournals.jbchem.a003204 PubMed Abstract | CrossRef Full Text | Google Scholar Lehman, W., Rosol, M., Tobacman, L. S., and Craig, R. (2001). Troponin organization on relaxed and activated thin filaments revealed by electron microscopy and three-dimensional reconstruction. J. Mol. Biol. 307, 739–744. doi: 10.1006/jmbi.2001.4514 PubMed Abstract | CrossRef Full Text | Google Scholar Mathur, M. C., Kobayashi, T., and Chalovich, J. M. (2009). Some cardiomyopathy causing troponin I mutations stabilize a functional intermediate actin state. Biophys. J. 96, 2237–2244. doi: 10.1016/j.bpj.2008.12.3909 PubMed Abstract | CrossRef Full Text | Google Scholar McKillop, D. F. A., and Geeves, M. A. (1991). Regulation of the actomyosin subfragment 1 interaction by troponin/tropomyosin. Evidence for control of a specific isomerization between two actoùmyosin subfragment 1 states. Biochem. J. 279, 711–718. PubMed Abstract Pirani, A., Xu, C., Hatch, V., Craig, R., Tobacman, L. S., and Lehman, W. (2005). Single particle analysis of relaxed and activated muscle thin filaments. J. Mol. Biol. 346, 761–772. doi: 10.1016/j.jmb.2004.12.013 PubMed Abstract | CrossRef Full Text | Google Scholar Poole, K. J. V., Lorenz, M., Evans, G., Rosenbaum, G., Pirani, A., Craig, R., et al. (2006). A comparison of muscle thin filament models obtained from electron microscopy reconstructions and low-angle X-ray fibre diagrams from non-overlap muscle. J. Struct. Biol. 155, 273–284. doi: 10.1016/j.jsb.2006.02.020 PubMed Abstract | CrossRef Full Text | Google Scholar Trybus, K. M., and Taylor, E. W. (1980). Kinetic studies of the cooperative binding of subfragment 1 to regulated actin. Proc. Natl. Acad. Sci. U.S.A. 77, 7209–7213. PubMed Abstract | Google Scholar Keywords: troponin, tropomyosin, cardiomyopathy, troponin T, mutations Citation: Chalovich JM and Johnson D (2016) Commentary: Effect of Skeletal Muscle Native Tropomyosin on the Interaction of Amoeba Actin with Heavy Meromyosin. Front. Physiol. 7:377. doi: 10.3389/fphys.2016.00377 Received: 28 June 2016; Accepted: 15 August 2016; Published: 31 August 2016. Edited by: Reviewed by: Copyright © 2016 Chalovich and Johnson. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. *Correspondence: Joseph M. Chalovich, chalovichj@ecu.edu

9 September 2020 in Biochemistry
Verified
Journal Article
Closed access
DJDylan Johnson
Dylan Johnson
Maicon Landim-VieiraMaicon Landim-Vieira
Maicon Landim-Vieira
CSChristopher Solı́s
Christopher Solı́s
LZLi Zhu
Li Zhu
JRJohn M. Robinson
John M. Robinson
JCJoseph Michael Chalovich
Joseph Michael Chalovich